Bristol Myers Squibb’s oncology-focused campaign was developed in partnership with 2025 MM+M Agency 100 honoree Real ...

Abortion bans generally don’t include exceptions that cover these kinds of medical emergencies — or if they do, doctors aren’t using them.

Richard Glasson, global chief executive of Hogarth, will oversee WPP Production, which will be made up of almost 10,000 ...

GSK is set to buy Rapt Therapeutics in a $2.2 billion deal. AstraZeneca agreed to a $630 million pact to secure remaining rights to armored CAR-T from AbelZeta. Bristol Myers Squibb signed a deal with ...

Impact XM CEO Jared Pollacco will serve as CEO of the unified agency and Jack Morton CEO Craig Millon will serve as global ...

Millions of middle-class Americans who have ACA health plans are facing soaring premium payments in 2026, without help from ...

Trump’s Great Healthcare Plan may not have much luck being passed into law. But it’s still a signal for pharma marketers to center affordability in their direct-to-patient relationships.

Relevate Health, a 2025 MM+M Agency 100 honoree, promoted Tara Hubbard and George Karyotakis to SVP of strategic solutions.

Is Europe raising its drug prices? Depends who you ask; ImmunityBio rally burns short-sellers; Elizabeth Holmes asks Trump for early release from prison.

Novo Nordisk developed There’s Only One Ozempic in partnership with Rogue Producer, an independent advertising and content ...

When the head of the nation’s largest publicly operated health plan worries about the looming federal cuts to Medicaid, it’s not just her job. It’s personal.

Leaders from medical marketing shops like AbelsonTaylor Group, Merge and Citrus Health weigh in on Omnicom’s impact on the Chicago ad scene.